Chemical & Pharmaceutical Bulletin published new progress about 5034-06-0. 5034-06-0 belongs to chlorides-buliding-blocks, auxiliary class Salt,Aliphatic hydrocarbon chain, name is trimethyloxosulphonium chloride, and the molecular formula is C3H9ClOS, Safety of trimethyloxosulphonium chloride.
Onuki, Yuta published the artcileRing-opening cyclization of spirocyclopropanes using sulfoxonium ylides, Safety of trimethyloxosulphonium chloride, the publication is Chemical & Pharmaceutical Bulletin (2020), 68(5), 479-486, database is CAplus and MEDLINE.
Ring-opening cyclization of cyclohexane-1,3-dione-2-spirocyclopropanes I (R = H, Me, Ph; R1 = H, Me; R2 = H, Ph, 4-methylphenyl, 4-bromophenyl, n-butyl; n = 1) using dimethylsulfoxonium methylide proceeded regioselectively to produce 2,3,4,6,7,8-hexahydro-5H-1-benzopyran-5-ones II (R3 = H; n = 1) in good to high yields. The reactions of cycloheptane- and cyclopentane-1,3-dione-2-spirocyclopropanes I (R = H; R1 = H; R2 = phenyl; n = 0 or 2) could construct [7.6]- and [5.6]-fused ring systems II (R3 = H; n = 0 or 2). This reaction was also carried out using triethyl(oxo)-sulfanylium chloride, tributyl(oxo)-sulfanylium chloride, and benzyldimethyloxo-sulfanylium chloride, resulting in the formation of the corresponding 2,3-trans-disubstituted products III (R4 = Ph; R5 = Me, Pr, phenyl) and II (R = H; R1 = H; R2 = H; R3 = Ph; n = 1) in good to high yields, and it was shown that the di-Me group can act as a dummy substituent. It was found that the 2- and 3-phenyhexahydrobenzopyran-5-ones II (R = H; R1 = H; R2 = H, phenyl; n = 1) can be readily converted into 5-hydroxyflavan and 5-hydroxyisoflavan, resp.
Chemical & Pharmaceutical Bulletin published new progress about 5034-06-0. 5034-06-0 belongs to chlorides-buliding-blocks, auxiliary class Salt,Aliphatic hydrocarbon chain, name is trimethyloxosulphonium chloride, and the molecular formula is C3H9ClOS, Safety of trimethyloxosulphonium chloride.
Referemce:
https://en.wikipedia.org/wiki/Chloride,
Chlorides – an overview | ScienceDirect Topics